摘要:
The present invention provides a fused heterocyclic derivative having a potent kinase inhibitory activity and use thereof.A compound represented by the formula (I): wherein each symbol is as defined in the specification, except a particular compound, or a salt thereof, and a pharmaceutical agent containing the compound or a prodrug thereof, which is a kinase (VEGFR, VEGFR2, PDGFR, Raf) inhibitor, an angiogenesis inhibitor, an agent for the prophylaxis or treatment of cancer, a cancer growth inhibitor or a cancer metastasis suppressor.
摘要:
The present invention provides a fused heterocyclic derivative having a potent kinase inhibitory activity and use thereof.A compound represented by the formula (I): wherein each symbol is as defined in the specification, except a particular compound, or a salt thereof, and a pharmaceutical agent containing the compound or a prodrug thereof, which is a kinase (VEGFR, VEGFR2, PDGFR, Raf) inhibitor, an angiogenesis inhibitor, an agent for the prophylaxis or treatment of cancer, a cancer growth inhibitor or a cancer metastasis suppressor.
摘要:
The present invention provides a fused heterocyclic derivative having a potent kinase inhibitory activity and use thereof.A compound represented by the formula (I): wherein each symbol is as defined in the specification, except a particular compound, or a salt thereof, and a pharmaceutical agent containing the compound or a prodrug thereof, which is a kinase (VEGFR, VEGFR2, PDGFR, Raf) inhibitor, an angiogenesis inhibitor, an agent for the prophylaxis or treatment of cancer, a cancer growth inhibitor or a cancer metastasis suppressor.
摘要:
The present invention provides an imidazopyridazine derivative compound having a potent kinase inhibitory activity and a pharmaceutical agent thereof useful for treatment or prevention of cancer and the like. One such compound is represented by the formula: or a salt thereof or a prodrug thereof. The pharmaceutical agent contains the imidazopyridazine derivative compound or a prodrug thereof, which is a kinase (VEGFR, VEGFR2, PDGFR, Raf) inhibitor, an angiogenesis inhibitor, an agent for the prophylaxis or treatment of cancer, a cancer growth inhibitor, or a cancer metastasis suppressor.
摘要:
The present invention provides a fused heterocyclic derivative having a strong kinase inhibitory activity and use thereof.The present invention relates to a compound represented by the formula wherein each symbol is as defined in the present specification, or a salt thereof.
摘要:
The present invention provides a fused heterocyclic derivative having a strong kinase inhibitory activity and use thereof.The present invention relates to a compound represented by the formula wherein each symbol is as defined in the present specification, or a salt thereof.
摘要:
In the case where X-ray tubes and X-ray detectors have fixed directions (directions of irradiation and directions of detecting planes), X-ray fluoroscopy can be carried out from various directions by providing two U-shaped tracks for the X-ray tubes and the X-ray detectors, each having two straight tracks arranged opposite each other, and a curved track connected thereto. An increased number of directions for X-ray fluoroscopy can be secured by arranging a U-shaped track rail for the X-ray tubes and a U-shaped track rail for the X-ray detectors opposite each other when seen in plane view.
摘要:
In a laser processing machine 100 including a plurality of element units containing at least a laser blower unit 3, an optical-path purge unit 24, and a temperature controlling unit 8, a measurement unit and a control unit 10 are provided. The measurement unit measures an elapsed time from a final trigger at which a laser processing operation of the laser processing machine has stopped and no user operation is applied with respect to the laser processing machine. The control unit 10 stops the element units based on the elapsed time after the final trigger, when a condition specified for each of the element units is satisfied.
摘要:
A first object is to offer a safety device that allows to effectively solve problems regarding transfusion including free-flow issues in the case where the transfusion tube comes off from the transfusion pump, by employing a comparatively simple structure constructed at a low cost. A second object is to offer a safety device that can be newly added to an existing transfusion pump having no safety device. Specifically speaking, the case 100 in a tubular shape having a base, the compression spring 130, and the clamp 10 having the movable body 120 are set in the socket 20 having a cross-sectional shape of a square bracket. When the clamp 10 is set in the socket 20, the through-holes 101 and 121 become open, which allows distribution of fluid in the transfusion tube. On the other hand, when the clamp 10 becomes detached from the socket 20, the tension of the compression spring 130 causes the movable body 120 to slide, and the through-holes 101 and 121 are closed. As a result, the transfusion tube is blocked off, preventing the occurrence of a free flow.
摘要:
A highly reliable vehicle driver's fatigue evaluating method is provided, which is capable of quantitatively calculating a degree of fatigue of a driver seated on a seat. The degree of fatigue of the driver seated on a seat is quantitatively calculated based on an amount of rearward deflection of a lower part of a backrest portion of the seat, a load applied downward to a front part of a seating portion of the seat, and a load applied rearward to an upper part of the backrest portion, in a state of the driver being seated on the seat.